Mabion S.A.

WSE:MAB.WA

19.28 (PLN) • At close December 14, 2023
Bedrijfsnaam Mabion S.A.
Symbool MAB.WA
Munteenheid PLN
Prijs 19.28
Beurswaarde 311,609,125
Dividendpercentage 0%
52-weken bereik 15.8 - 24.9
Industrie Biotechnology
Sector Healthcare
CEO Mr. Krzysztof Kaczmarczyk
Website https://www.mabion.eu

An error occurred while fetching data.

Over Mabion S.A.

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and

Vergelijkbare Aandelen

BIOTON S.A. logo

BIOTON S.A.

BIO.WA

3.64 PLN

Captor Therapeutics Spolka Akcyjna logo

Captor Therapeutics Spolka Akcyjna

CTX.WA

105 PLN

Ryvu Therapeutics S.A. logo

Ryvu Therapeutics S.A.

RVU.WA

64.5 PLN

Mercator Medical S.A. logo

Mercator Medical S.A.

MRC.WA

41.48 PLN

Celon Pharma S.A. logo

Celon Pharma S.A.

CLN.WA

15.96 PLN

Medicalgorithmics S.A. logo

Medicalgorithmics S.A.

MDG.WA

32.35 PLN

Selvita S.A. logo

Selvita S.A.

SLV.WA

59.7 PLN

NEUCA S.A. logo

NEUCA S.A.

NEU.WA

843 PLN

Financiële Gegevens

Cijfers zijn in miljoenen (PLN)

Cijfers zijn in miljoenen (PLN)